Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2006 4
2007 4
2008 6
2009 10
2010 8
2011 23
2012 20
2013 21
2014 25
2015 48
2016 32
2017 37
2018 55
2019 17
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Results by year
Filters applied: . Clear all
Page 1
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.
Kosloski MP, Zhao W, Asatryan A, Kort J, Geoffroy P, Liu W. Kosloski MP, et al. Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00958-17. doi: 10.1128/AAC.00958-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28807904 Free PMC article. Clinical Trial.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J. Lee JD, et al. Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14. Lancet. 2018. PMID: 29150198 Free PMC article. Clinical Trial.
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Tanum L, Solli KK, Latif ZE, Benth JŠ, Opheim A, Sharma-Haase K, Krajci P, Kunøe N. Tanum L, et al. JAMA Psychiatry. 2017 Dec 1;74(12):1197-1205. doi: 10.1001/jamapsychiatry.2017.3206. JAMA Psychiatry. 2017. PMID: 29049469 Free PMC article. Clinical Trial.
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD, Diaper AM, Melichar JK, Coulton S, Nutt DJ, Myles JS. Law FD, et al. J Psychopharmacol. 2017 Aug;31(8):1046-1055. doi: 10.1177/0269881117711710. Epub 2017 Jun 20. J Psychopharmacol. 2017. PMID: 28631527 Free article. Clinical Trial.
Buprenorphine-naloxone.
Hu T, Nijmeh L, Pyle A. Hu T, et al. CMAJ. 2018 Nov 26;190(47):E1389. doi: 10.1503/cmaj.180776. CMAJ. 2018. PMID: 30478217 Free PMC article. No abstract available.
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.
Jönsson M, Mundin G, Sumner M. Jönsson M, et al. Eur J Pharm Sci. 2018 Sep 15;122:125-133. doi: 10.1016/j.ejps.2018.06.024. Epub 2018 Jun 22. Eur J Pharm Sci. 2018. PMID: 29940217 Clinical Trial.
282 results
Jump to page
Feedback